Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects

Antishivering Effects Clinical Trial

Official title:

Diluting With Cerebrospinal Fluid Versus Traditional Intrathecal Administration: Antishivering Effects

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02189655
• Other study ID #: 20140630
• Status: Withdrawn
• Phase: N/A
• Start date: March 2016
• Est. completion date: December 2021

Study information

• Verified date: November 2019
• Source: China Medical University, China
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This prospective randomized double-blinded study was conducted to compare the antishivering effects of two different types of intrathecal administration.

Description:

This prospective randomized double-blinded study was conducted to compare the antishivering effects of two different types of intrathecal administration.Group Control:traditional intrathecal administration; Group Diluting:Diluting with cerebrospinal fluid

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: December 2021
• Est. primary completion date: December 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• American Society of Anesthesiologists (ASA) physical status ? or ? who were scheduled for elective surgery under spinal anesthesia were enrolled.

Exclusion Criteria:

• Patients with pre-operative fever (>38?), diabetes, , Parkinson's disease, hypo or hyperthyroidism, Raynaud's syndrome, obese patients (weight >100 kg), patients shorter than 152 cm, those with a history of allergy to the study medications, and patients receiving vasodilators were excluded from the study.

Related Conditions & MeSH terms

• Antishivering Effects

Intervention

Procedure:
• bupivacaine 0.5% 2.5 mL diluting with cerebrospinal fluid
Hyperbaric bupivacaine 0.5% 2.5 mL diluting with cerebrospinal fluid was administered intrathecally in 30 seconds

Locations

Country	Name	City	State
China	the First Hospital of China Medical University	Shenyang	Liaoning

Sponsors (1)

Lead Sponsor	Collaborator
China Medical University, China

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	antishivering effects of two different types of spinal anesthesia	antishivering effects of two different types administration of spinal anesthesia	time point 1: 15 minuntes after spinal anesthesia and time point 2 : when patiets were sent to postoperation care unit